# Research Gaps

## 80/20 priority rule

Broad research is closed. Pursue a gap only when it materially changes the corporate chronology, resolves a major contradiction, establishes Benny's role, identifies a principal photograph, or prevents a misleading publication statement.

### Priority A — material before editorial lock

- Benny's role, dates, engaging entity, financial participation and loss documentation.
- Identification and purpose of the formal meeting in `img00786_5091848292_o.jpg`.
- Correction of key oral-history names and the New York/Russia chronology.
- Underlying evidence required before attributing named nuclear-sector contracts or completed acquisitions.
- Separation of completed transactions from proposals and public claims.

### Priority B — useful if readily available

- Nucon-RUS formation/accreditation record and ATOLL share register.
- Transfer-agent confirmation of material share-count discrepancies.
- Original agreements already known by exact name or date.
- Travel documents that resolve the 2008 itinerary.

### Deferred — preserve as unresolved and move on

- Duplicate newswire copies.
- Minor landmark identification.
- Speculative leads without a named document, person or proceeding.
- Exhaustive reconstruction of immaterial issuances or technologies.
- Negative-proof research attempting to establish that no litigation or dispute ever existed.

## Corporate and securities records

1. Nevada-certified articles and every name-change amendment from Pacific Hothouse through NNRF.
2. May 2006 share-exchange agreement and complete schedule of the 49 Nucon recipients.
3. Transfer-agent ledger covering the reverse merger, 2006–08 issuances, escrow shares, warrants and options.
4. DTC/FINRA corporate-action records beyond the recovered September 2007 DTCC notice.
5. Complete SEC accession/exhibit inventory, including the 2009 Form D and correspondence.
6. Explanation and records for the 2010–2022 public-information gap.
7. State and issuer records supporting the 2023 authorized-share increase.
8. Transfer-agent resolution of the 449,721,550 versus 449,921,550 2023 year-end share-count discrepancy.
9. Direct Nevada status record after the issuer stated it was in default in March 2026.

## Russian corporate and operating records

1. Nucon-RUS formation, accreditation, officers, address and share register.
2. Executed ATOLL agreements, amendments, certified translations, payment records and board minutes.
3. Evidence explaining the real-estate spinout from ATOLL.
4. ATOLL customer ledger and the contract set behind the $183 million announcement.
5. Rosenergoatom and Atomstroyexport confirmations, contracts and purchase orders.
6. ATOLL audited Russian financial statements and reconciliation to the SEC summary.
7. Velcont and Electroprivod agreements, closing/payment records and final ownership percentages.
8. Russian licenses and certifications cited for ATOLL, Velcont, Electroprivod and Lutch.
9. ECNC formation, ownership and operational records.
10. Outcome documents for RUAR and other proposed Russian acquisitions.

## Technology and agreement records

1. FEECOM/BIECOM agreement, patent application, tests, commercialization and royalty records.
2. NuCap ownership/licensing chain, certification, customs and sales records.
3. TRUMEM source agreement and technical validation.
4. TPA Ltd, TRI-ION, Environmental Potentials/Power Quality, ASE/Chernobyl and Nuclear Sites Decommissioning agreements and results.
5. Source documents for claimed Korean nuclear-industry activity.

## Later-company records

1. Kading Company exchange agreement and Business Warrior conversion documents.
2. 2015 Wi-Fi acquisition agreement, closing, financing and disposition.
3. Elevate Nutraceutics purchase agreement, valuation and dissolution record.
4. Elevate Biologix formation documents and current operations.
5. Earth Sciences subscription agreement, receipts and share ledger.
6. Zeolite Australia and Tennessee greenhouse LOIs, diligence, amendments and termination/closing records.
7. Auditor workpapers or independent financial verification for current OTC periods.

## Benny Doro role

1. Exact title, dates, contracting entity and reporting line.
2. Compensation, shares, warrants, expense reimbursement or financing participation.
3. Emails, calendars, itineraries and introductions connected to the 2008 Russia trip.
4. Identification of all people and meetings in the photo archive.
5. Documents connecting Benny to ATOLL, Nucon-RUS or other Russian counterparties.
6. Review/correction of the machine transcript and a replacement final narration if desired.

## Legal and risk

1. Full litigation search across federal, Nevada, New York, Canadian and relevant Russian sources.
2. Evidence regarding the internal counterfeit-share question.
3. Defaults, note disputes, transfer restrictions, cancelled deals or enforcement correspondence not visible in the reviewed filings.

## Excluded source

`financialReportViewer.pdf` is excluded because Benny stated that it does not belong to the historical company. It must not be used, copied into the evidence archive or cited.